Bookmark and Share

William A. Blattner

William A. Blattner M.D.

Academic Title: Professor
Primary Appointment: Medicine
Secondary Appointments: Epidemiology & Public Health
Additional Title(s): Please see below
Location: Institute of Human Virology, Room N449
Phone: (410) 706-1941
Fax: (410) 706-1944

Personal History:

Additional Titles

  • Co-Founder and Associate Director - Institute of Human Virology
  • Director - Division of Epidemiology and Prevention (1995-2015), Institute of Human Virology
  • Associate Director - Population Research, Greenebaum Cancer Center (2009-2015)
  • Chief - Division of Cancer Epidemiology, Department of Epidemiology and Preventative Medicine

Dr. Blattner is Professor of Medicine and Epidemiology and Public Health and Co-Founder and Associate Director of the Institute of Human Virology where he has led an epidemiology research program targeting HIV and cancer. He is an internationally renowned authority on the epidemiology of human retroviruses, HTLV and HIV and the viral epidemiology of cancer.  He co-founded the Institute of Human Virology, Nigeria where he led a large PEPFAR program that engaged principles of implementation science to provide services to over 2 million clients. The IHV-Nigeria International Research Center of Excellence provides a platform for research studies of key populations at high risk for HIV and a growing program of cancer research.

In 2009 he assumed responsibility as Associate Director for Population Research at the Greenebaum Cancer Center where he has guided the development of the Population Research Program, a partnership with the University of Maryland College Park.

Before coming to the University of Maryland, Dr. Blattner graduated from Washington University School of Medicine, interned at Strong Memorial Hospital, completed residencies at the New York Cornell Medical Center and Memorial Sloan Kettering Cancer Institute, and did his medical oncology training at the National Cancer Institute in Bethesda where he served in the Public Health Service for 22 years and was a Research Branch Chief. 

He is Board Certified in Internal Medicine and Medical Oncology. Among his notable achievements are his studies of etiology of HTLV-1 in adult T-cell leukemia, the role of the p53 mutation in Li Fraumeni Syndrome, and his seminal research on HIV spanning 40 years.


  1. Dolcetti R, Giagulli C, He W, Selleri M, Caccuri F, Eyzaguirre LM, Mazzuca P, Corbellini S, Campilongo F, Marsico S, Giombini E, Murano E, Rozera G, De Paoli P, Carbone A Capobianchi MR, Ippolito G, Fiorntini S, Blattner WA, Lu W, Gallo RC, Caruso A. Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis Proceedings of the National Academy of Sciences of the United States of America. 2015;(in press).
  2. Schwartz SR, Nowak RG, Orazulike I, Keshinro B, Ake J, Kennedy S, Njoku O, Blattner WA, Charurat ME, Baral SD; TRUST Study Group. The immediate effect of the Same-Sex Marriage Prohibition Act on stigma, discrimination, and engagement on HIV prevention and treatment services in men who have sex with men in Nigeria: analysis of prospective data from the TRUST cohort. Lancet HIV. 2015 Jul 1;2(7):e299-e306.
  3. Riedel DJ1, Rositch AF, Redfield RR, Blattner WA. HIV-associated lymphoma sub-type distribution, immunophenotypes and survival in an urban clinic population. Leuk Lymphoma. 2015 Jun 19:1-7. [Epub ahead of print]
  4. Ugoji C, Okere N, Dakum P, Ake-Uzoigwe R, Igboelina D, Ndembi N, Ekong E, Charurat M, Blattner WA Correlates of Patient Retention in HIV Care and Treatment Programs in Nigeria. Curr HIV Res. 2015;13(4):300-7.
  5. Charurat M, Emmanuel B, Akolo C, Keshinro B, Nowak R, Kennedy S, Orazulike I, Ake J, Njoku O, Baral S, Blattner W, for the TURST Study Group. Uptake of Treatment as Prevention for HIV and Continuum of Care among HIV-positive Men who have Sex with Men in Nigeria. J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S114-23. doi: 10.1097/QAI.0000000000000439.PMID:25723975
  6. Akolo C, Royal W 3rd, Cherner M, Okwuasaba K, Eyzaguirre L, Adebiyi R, Umlauf A, Hendrix T, Johnson J, Abimiku A, Blattner WA. Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria. J Neurovirol. 2014 Aug;20(4):380-7.
  7. Weiss SH, Goedert JJ, Sarngadharan MG, Bodner AJ; AIDS Seroepidemiology Collaborative Working Group, Gallo RC, Blattner WA. Screening test for HTLV-III (AIDS agent) antibodies: specificity, sensitivity, and applications. JAMA. 2014 Jul 23-30;312(4):442. (Republication of seminal article from 1985 in JAMA Revisited).
  8. Aliyu, G., El-Kamary, S.S., Abimiku, A., Brown, C., Tracy, K., Hungerford, L., Blattner, W. Prevalence of Non-Tuberculous Mycobacterial Infections among Tuberculosis Suspects in Nigeria. PLoS One. 2013 May 9;8(5):e63170.
  9. Etiebet MA, Shepherd J, Nowak RG, Charurat M, Chang H, Ajayi S, Elegba O, Ndembi N, Abimiku A, Carr JK, Eyzaguirre LM, Blattner W.A., Tenofovir-based regimens associated with less drug resistance in HIV-1-infected Nigerians failing first-line antiretroviral therapy. AIDS. 2013 Feb 20;27(4):553-61.
  10. Jedy-Agba, E., Curado, M.P., Ogunbiyi, O., Oga, E., Fabowale, T., Igbinoba, F., Osubor, G., Out, T., Kumai, H., Koechlin, A., Osinubi, P., Dakum, P., Blattner, W., Adebamowo, C.A. Cancer incidence in Nigeria: A report from population-based cancer registries. Cancer Epidemio. 2012 Oct;36(5):e271-8. Epub 2012 May 22.
  11. Cote, T.R., Biggar, R.J., Rosenberg, P.S., Devesa, S.S., Percy, C., Yellin, F.J., Lemp, G., Hardy, C., Geodert, J.J., and Blattner, W.A. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/ Cancer Study Group. Int J Cancer. 1997 Nov 27;73(5):645–50. PMID: 9398040.
  12. Rattray, C., Strickler, H.D., Escoffery, C., Cranston, B., Brown, C., Manns, A., Schiffman, M.H., Palefsky, J.M., Hanchard, B., and Blattner, W.A. Type-specific prevalence of human papillomavirus DNA among Jamaican colposcopy patients. J Infect Dis. 1996 Mar;173(3):718–21. PMID: 8627038.
  13. Strickler, H.D., Rattray, C., Escoffery, C., Manns, A., Schiffman, M.H., Palefsky, J.M., Hanchard, B. and Blattner, W.A. Human T-cell lymphotropic virus type I and severe cervical neoplasia in Jamaica. Int J Cancer. 1995 Mar 29;61(1):23–6. PMID: 7705929.
  14. Cleghorn, F.R., Manns, A., Falk, R., Hartge, P., Hanchard, B., Jack, N., Williams, E., Jaffe, E., White, F., Bartholomew, C., and Blattner, W.A. Effect of Human T-Lymphotropic Virus Type I infection on Non-Hodgkin’s Lymphoma incidence. J Nat Cancer Inst. 1995 Jul 5;87(13):1009–14. PMID: 7629870.
  15. Cote, T.R., Biggar, R.J., Rosenberg, P.S., Devesa, S.S., Percy, C., Yellin, F.J., Lemp, G., Hardy, C., Geodert, J.J., and Blattner, W.A. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/ Cancer Study Group. Int J Cancer. 1997 Nov 27;73(5):645–50. PMID: 9398040.